Repligen (RGEN): are the analysts right?

Repligen · Health Care · ref. ETF XLV · 57 calls · price $139.86
What the company does: Repligen développe et commercialise technologies bioprocesses pour industries pharmaceutiques et biotechnologiques.
📈 1-year price
$139.83+8.8% over range
Jul 8, 25low $102.87 · high $172.26Jul 7, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
89% recommend buying · 9 analysts

🎯 Analyst price target on RGEN

High target · 1 analyst$208+48.7%
Median target · 9 analysts$160+14.4%
Low target · 1 analyst$140+0.1%
Current price$139.86

🗳️ The analyst consensus

Analyst breakdown · 9 (6 months)
Strong Buy0%
Buy89%
Hold11%
Sell0%
Strong Sell0%

✅ Historical analyst reliability on RGEN

Most reliable analysts on RGEN (% profitable · 365j · ≥2 calls)
HC Wainwright & Co. 55% +25.6% 11
RBC Capital 0% -18.9% 4
JP Morgan 0% -19.0% 4

📊 What $1,000 invested in Repligen would be worth

In short — $1,000 invested in Repligen 10 years ago would be worth $4,823 today, i.e. +17%/yr on average. Best year: 2020 (+107%), worst: 2022 (-36%). Price performance, excluding dividends.

If I'd invested $1,000 in Repligen

InvestmentWorth todayGain
1 years ago$948-5%
3 years ago$806-19%
5 years ago$712-29%
10 years ago$4,823+382%
since inception (1986)$12,546+1155%

Return by year (Repligen)

YearReturn$1,000 invested at year start
2026 (YTD)-17%$833 (-17%)
2025+14%$948 (-5%)
2024-20%$759 (-24%)
2023+6%$806 (-19%)
2022-36%$515 (-48%)
2021+38%$712 (-29%)
2020+107%$1,475 (+48%)
2019+75%$2,587 (+159%)
2018+45%$3,761 (+276%)
2017+18%$4,427 (+343%)
2016+9%$4,823 (+382%)
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

🔎 Detailed analyses

👥 Analysts & forecasts📊 Returns & performance
📈 Fundamentals, technical momentum and live news will show here on the final site (loaded live from the same origin as the API).

📋 All analyst calls on RGEN

HSBC
Jun 3, 26
▲ Buy · 🎯$150
Price at call : $126.55 — upside +19%
Today : $139.86 — upside +7%
🎯 on RGEN : no call matured yet · 📊 overall : 38.5% · -3.5% (26 calls)
in progress (365j)
matures : Jun 3, 27
JP Morgan
May 6, 26
▲ Overweight · 🎯$165
Price at call : $126.43 — upside +31%
Today : $139.86 — upside +18%
🎯 on RGEN : 0% (4 calls matureds) · 📊 on Health : 48.4% · +4.8% (126 calls)
in progress (365j)
matures : May 6, 27
Barclays
May 6, 26
▲ Overweight · 🎯$160
Price at call : $126.43 — upside +27%
Today : $139.86 — upside +14%
🎯 on RGEN : 100% (1 call matured) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : May 6, 27
■ Hold neutral · not a buy · 🎯$145
Price at call : $132.7 — gap to target +9%
Today : $139.86 — gap to target +4%
🎯 on RGEN : no call matured yet · 📊 on Health : 52.2% · +6.5% (90 calls)
in progress (365j)
matures : Apr 20, 27
Roth Capital
Apr 17, 26
▲ Buy · 🎯$160
Price at call : $131.99 — upside +21%
Today : $139.86 — upside +14%
🎯 on RGEN : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Apr 17, 27
Barclays
Apr 14, 26
▲ Overweight · 🎯$145
Price at call : $131.93 — upside +10%
Today : $139.86 — upside +4%
🎯 on RGEN : 100% (1 call matured) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Apr 14, 27
▲ Outperform · 🎯$140
Price at call : $115.29 — upside +21%
Today : $139.86 — upside +0%
🎯 on RGEN : no call matured yet · 📊 on Health : 35.3% · -9.2% (34 calls)
in progress (365j)
matures : Apr 6, 27
▲ Buy · 🎯$208
Price at call : $116.35 — upside +79%
Today : $139.86 — upside +49%
🎯 on RGEN : 55% (11 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : Mar 23, 27
UBS
Feb 25, 26
▲ Buy · 🎯$195
Price at call : $133.65 — upside +46%
Today : $139.86 — upside +39%
🎯 on RGEN : 0% (1 call matured) · 📊 on Health : 47.1% · +16.6% (102 calls)
in progress (365j)
matures : Feb 25, 27
Barclays
Feb 25, 26
▲ Overweight · 🎯$175
Price at call : $133.65 — upside +31%
Today : $139.86 — upside +25%
🎯 on RGEN : 100% (1 call matured) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Feb 25, 27
Wells Fargo
Feb 25, 26
▲ Overweight · 🎯$180
Price at call : $133.65 — upside +35%
Today : $139.86 — upside +29%
🎯 on RGEN : 0% (1 call matured) · 📊 on Health : 46% · +2.8% (126 calls)
in progress (365j)
matures : Feb 25, 27
▲ Outperform · 🎯$170
Price at call : $132.14 — upside +29%
Today : $139.86 — upside +22%
🎯 on RGEN : no call matured yet · 📊 on Health : 35.3% · -9.2% (34 calls)
in progress (365j)
matures : Feb 25, 27
UBS
Jan 16, 26
▲ Buy · 🎯$200
Price at call : $163.33 — upside +22%
Today : $139.86 — upside +43%
🎯 on RGEN : 0% (1 call matured) · 📊 on Health : 47.1% · +16.6% (102 calls)
in progress (365j)
matures : Jan 16, 27
Barclays
Dec 15, 25
▲ Overweight · 🎯$200
Price at call : $158.09 — upside +27%
Today : $139.86 — upside +43%
🎯 on RGEN : 100% (1 call matured) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Dec 15, 26
Wells Fargo
Dec 15, 25
▲ Overweight · 🎯$190
Price at call : $158.09 — upside +20%
Today : $139.86 — upside +36%
🎯 on RGEN : 0% (1 call matured) · 📊 on Health : 46% · +2.8% (126 calls)
in progress (365j)
matures : Dec 15, 26
■ Hold neutral · not a buy · 🎯$165
Price at call : $144.57 — gap to target +14%
Today : $139.86 — gap to target +18%
🎯 on RGEN : no call matured yet · 📊 on Health : 52.2% · +6.5% (90 calls)
in progress (365j)
matures : Oct 29, 26
Barclays
Oct 29, 25
▲ Overweight · 🎯$175
Price at call : $144.57 — upside +21%
Today : $139.86 — upside +25%
🎯 on RGEN : 100% (1 call matured) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Oct 29, 26
▲ Outperform · 🎯$175
Price at call : $150.81 — upside +16%
Today : $139.86 — upside +25%
🎯 on RGEN : no call matured yet · 📊 on Health : 35.3% · -9.2% (34 calls)
in progress (365j)
matures : Oct 7, 26
Barclays
Oct 2, 25
▲ Overweight · 🎯$160
Price at call : $145.23 — upside +10%
Today : $139.86 — upside +14%
🎯 on RGEN : 100% (1 call matured) · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Oct 2, 26
HSBC
Oct 1, 25
▲ Buy · 🎯$150
Price at call : $145.23 — upside +3%
Today : $139.86 — upside +7%
🎯 on RGEN : no call matured yet · 📊 overall : 38.5% · -3.5% (26 calls)
in progress (365j)
matures : Oct 1, 26
▲ Outperform · 🎯$155
Price at call : $125.94 — upside +23%
Today : $139.86 — upside +11%
🎯 on RGEN : no call matured yet · 📊 on Health : 35.3% · -9.2% (34 calls)
in progress (365j)
matures : Sep 22, 26
Jefferies
Sep 12, 25
■ Hold neutral · not a buy · 🎯$135
Price at call : $113.54 — gap to target +19%
Today : $139.86 — gap to target -3%
🎯 on RGEN : no call matured yet · 📊 on Health : 48% · +9.7% (98 calls)
in progress (365j)
matures : Sep 12, 26
▲ Buy · 🎯$180
Price at call : $116.18 — upside +55%
Today : $139.86 — upside +29%
🎯 on RGEN : 55% (11 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : Sep 3, 26
RBC Capital
Jul 30, 25
▲ Outperform · 🎯$204
Price at call : $117.07 — upside +74%
Today : $139.86 — upside +46%
🎯 on RGEN : 0% (4 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
in progress (365j)
matures : Jul 30, 26
Wells Fargo
Jul 30, 25
▲ Overweight · 🎯$175
Price at call : $117.07 — upside +49%
Today : $139.86 — upside +25%
🎯 on RGEN : 0% (1 call matured) · 📊 on Health : 46% · +2.8% (126 calls)
in progress (365j)
matures : Jul 30, 26
■ In-Line neutral · not a buy · 🎯$130
Price at call : $128.56 — gap to target +1%
Today : $139.86 — gap to target -7%
🎯 on RGEN : no call matured yet · 📊 on Health : 35.3% · -9.2% (34 calls)
in progress (365j)
matures : Jul 8, 26
Barclays
Jun 24, 25
▲ Overweight · 🎯$150
Price at call : $123.35 — upside +22%
Today : $139.86 — upside +7%
Expected +22% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on RGEN : 100% (1 call matured) · 📊 on Health : 47.8% · +1.6% (186 calls)
+12.2%
stock +12% · XLV +15%
▲ Buy · 🎯$180
Price at call : $140.92 — upside +28%
Today : $139.86 — upside +29%
Expected +28% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on RGEN : 55% (11 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
-10.9%
stock -11% · XLV +5%
RBC Capital
Apr 30, 25
▲ Outperform · 🎯$189
Price at call : $137.2 — upside +38%
Today : $139.86 — upside +35%
Expected +38% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on RGEN : 0% (4 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
-14.6%
stock -15% · XLV +6%
JP Morgan
Apr 29, 25
▲ Overweight · 🎯$190
Price at call : $137.99 — upside +38%
Today : $139.86 — upside +36%
Expected +38% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on RGEN : 0% (4 calls matureds) · 📊 on Health : 48.4% · +4.8% (126 calls)
-14.3%
stock -14% · XLV +4%
■ Hold neutral · not a buy · 🎯$150
Price at call : $130 — gap to target +15%
Today : $139.86 — gap to target +7%
🎯 on RGEN : no call matured yet · 📊 on Health : 52.2% · +6.5% (90 calls)
in progress (365j)
matures : Apr 16, 26
■ In-Line neutral · not a buy · 🎯$155
Price at call : $144.34 — gap to target +7%
Today : $139.86 — gap to target +11%
🎯 on RGEN : no call matured yet · 📊 on Health : 35.3% · -9.2% (34 calls)
in progress (365j)
matures : Mar 18, 26
RBC Capital
Feb 21, 25
▲ Outperform · 🎯$205
Price at call : $164.74 — upside +24%
Today : $139.86 — upside +47%
Expected +24% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on RGEN : 0% (4 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
-17.8%
stock -18% · XLV +7%
JP Morgan
Feb 21, 25
▲ Overweight · 🎯$200
Price at call : $164.74 — upside +21%
Today : $139.86 — upside +43%
Expected +21% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on RGEN : 0% (4 calls matureds) · 📊 on Health : 48.4% · +4.8% (126 calls)
-17.8%
stock -18% · XLV +7%
▲ Buy · 🎯$180
Price at call : $158.99 — upside +13%
Today : $139.86 — upside +29%
Expected +13% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on RGEN : 55% (11 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
-14.8%
stock -15% · XLV +8%
■ Hold neutral · not a buy · 🎯$170
Price at call : $158.99 — gap to target +7%
Today : $139.86 — gap to target +22%
🎯 on RGEN : no call matured yet · 📊 on Health : 52.2% · +6.5% (90 calls)
in progress (365j)
matures : Feb 21, 26
▲ Buy · 🎯$180
Price at call : $167.9 — upside +7%
Today : $139.86 — upside +29%
Expected +7% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on RGEN : 55% (11 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
-3.3%
stock -3% · XLV +9%
▲ Buy · 🎯$180
Price at call : $166.84 — upside +8%
Today : $139.86 — upside +29%
Expected +8% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on RGEN : 55% (11 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+0.7%
stock +1% · XLV +11%
■ Hold neutral · not a buy · 🎯$165
Price at call : $147.34 — gap to target +12%
Today : $139.86 — gap to target +18%
🎯 on RGEN : no call matured yet · 📊 on Health : 52.2% · +6.5% (90 calls)
in progress (365j)
matures : Dec 17, 25
■ Peer Perform neutral · not a buy
🎯 on RGEN : no call matured yet · 📊 on Health : 46.2% · +2.9% (13 calls)
in progress (365j)
matures : Nov 14, 25
RBC Capital
Sep 26, 24
▲ Outperform · 🎯$205
Price at call : $145.93 — upside +40%
Today : $139.86 — upside +47%
Expected +40% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on RGEN : 0% (4 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
-15.0%
stock -15% · XLV -11%
Wells Fargo
Aug 28, 24
▲ Overweight · 🎯$180
Price at call : $145.43 — upside +24%
Today : $139.86 — upside +29%
Expected +24% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on RGEN : 0% (1 call matured) · 📊 on Health : 46% · +2.8% (126 calls)
-16.0%
stock -16% · XLV -12%
Benchmark
Aug 5, 24
■ Hold neutral · not a buy
🎯 on RGEN : no call matured yet · 📊 on Health : 70% · +18.4% (10 calls)
in progress (365j)
matures : Aug 5, 25
JP Morgan
Jul 31, 24
▲ Overweight · 🎯$200
Price at call : $165.67 — upside +21%
Today : $139.86 — upside +43%
Expected +21% · Actual -28% · Reason (≥ +15%) : ✗ No
🎯 on RGEN : 0% (4 calls matureds) · 📊 on Health : 48.4% · +4.8% (126 calls)
-28.2%
stock -28% · XLV -13%
UBS
Jul 31, 24
▲ Buy · 🎯$185
Price at call : $165.67 — upside +12%
Today : $139.86 — upside +32%
Expected +12% · Actual -28% · Reason (≥ +15%) : ✗ No
🎯 on RGEN : 0% (1 call matured) · 📊 on Health : 47.1% · +16.6% (102 calls)
-28.2%
stock -28% · XLV -13%
RBC Capital
Jul 31, 24
▲ Outperform · 🎯$190
Price at call : $165.67 — upside +15%
Today : $139.86 — upside +36%
Expected +15% · Actual -28% · Reason (≥ +15%) : ✗ No
🎯 on RGEN : 0% (4 calls matureds) · 📊 on Health : 48.9% · +4.9% (186 calls)
-28.2%
stock -28% · XLV -13%
▲ Overweight · 🎯$170
Price at call : $167.35 — upside +2%
Today : $139.86 — upside +22%
Expected +2% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on RGEN : 0% (1 call matured) · 📊 on Health : 62.2% · +10.1% (37 calls)
-30.0%
stock -30% · XLV -13%
Deutsche Bank
Jun 26, 24
▲ Buy · 🎯$155
Price at call : $127 — upside +22%
Today : $139.86 — upside +11%
Expected +22% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on RGEN : 0% (1 call matured) · 📊 on Health : 51.3% · +8.7% (76 calls)
-2.2%
stock -2% · XLV -8%
Guggenheim
Jun 18, 24
■ Neutral neutral · not a buy
🎯 on RGEN : no call matured yet · 📊 on Health : 63.4% · +15.5% (41 calls)
in progress (365j)
matures : Jun 18, 25
JP Morgan
May 2, 24
▲ Overweight · 🎯$200
Price at call : $167.05 — upside +20%
Today : $139.86 — upside +43%
Expected +20% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on RGEN : 0% (4 calls matureds) · 📊 on Health : 48.4% · +4.8% (126 calls)
-15.6%
stock -16% · XLV -2%
▲ Buy · 🎯$240
Price at call : $194.81 — upside +23%
Today : $139.86 — upside +72%
Expected +23% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on RGEN : 55% (11 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
-18.6%
stock -19% · XLV +6%
▲ Buy · 🎯$225
Price at call : $207.02 — upside +9%
Today : $139.86 — upside +61%
Expected +9% · Actual -24% · Reason (≥ +15%) : ✗ No
🎯 on RGEN : 55% (11 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
-24.3%
stock -24% · XLV +17%
▲ Buy · 🎯$168
Price at call : $145.99 — upside +15%
Today : $139.86 — upside +20%
Expected +15% · Actual +85% · Reason (≥ +15%) : ✓ Yes
🎯 on RGEN : 55% (11 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+85.2%
stock +85% · XLV +28%
▲ Buy · 🎯$151
Price at call : $123.61 — upside +22%
Today : $139.86 — upside +8%
Expected +22% · Actual +61% · Reason (≥ +15%) : ✓ Yes
🎯 on RGEN : 55% (11 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+61.5%
stock +61% · XLV +26%
▲ Buy · 🎯$143
Price at call : $122.25 — upside +17%
Today : $139.86 — upside +2%
Expected +17% · Actual +54% · Reason (≥ +15%) : ✓ Yes
🎯 on RGEN : 55% (11 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+53.6%
stock +54% · XLV +25%
▲ Buy · 🎯$100
Price at call : $94.68 — upside +6%
Today : $139.86 — upside -28%
Expected +6% · Actual +100% · Reason (≥ +15%) : ✓ Yes
🎯 on RGEN : 55% (11 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+99.7%
stock +100% · XLV +42%
▲ Buy
Actual +53% · Reason (≥ +15%) : ✓ Yes
🎯 on RGEN : 55% (11 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+52.9%
stock +53% · XLV +16%
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)